Merck Stock Plummets 5.32% with 14.95 Billion Shares Traded Ranking 66th in Market Activity as Securities Fraud Lawsuit Looms

On April 10, 2025, Merck & Co., Inc. (MRK) experienced a significant decline in its stock price, dropping by 5.32%. The company's trading volume reached 14.95 billion, ranking it 66th in the day's market activity.

Investors who have incurred losses due to Merck's stock performance are now being given the opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that Merck and its executives failed to disclose crucial information regarding the demand for Gardasil in China, leading to an inflated inventory of its distributor. This misrepresentation is claimed to have materially affected the company's business, operations, and prospects, resulting in misleading statements to investors.

The complaint filed in the lawsuit covers a period from February 3, 2022, to February 3, 2025. It highlights that Merck lacked visibility into the demand for Gardasil among eligible populations in China, which led to an overestimation of inventory levels. This lack of transparency is alleged to have misled investors about the company's financial health and future prospects.

Investors who believe they have been adversely affected by these alleged misrepresentations are encouraged to participate in the class action lawsuit. The deadline for investors to join the lawsuit as lead plaintiffs is April 14, 2025. Those interested in learning more about the lawsuit or their rights as shareholders are advised to contact the law firms involved for further information.